Blue Owl Capital Holdings LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $234 Million distributed in 80 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pliant Therapeutics, Inc. with a value of $36.5M, Cullinan Oncology, Inc. with a value of $28.9M, Owl Rock Capital Corp with a value of $27.4M, Conduent Inc with a value of $22.7M, and Ever Commerce Inc. with a value of $18.1M.

Examining the 13F form we can see an decrease of $69.4M in the current position value, from $303M to 234M.

Blue Owl Capital Holdings LP is based out at New York, NY

Below you can find more details about Blue Owl Capital Holdings LP portfolio as well as his latest detailed transactions.

Portfolio value $234 Million
Healthcare: $149 Million
Technology: $45.8 Million
Financial Services: $29.4 Million
Consumer Cyclical: $9.03 Million
Energy: $981,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 80
  • Current Value $234 Million
  • Prior Value $303 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 11 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Blue Owl Capital Holdings LP Portfolio

Follow Blue Owl Capital Holdings LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Owl Capital Holdings LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Owl Capital Holdings LP with notifications on news.